Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-122
Closed -$11.2K 951
2023
Q2
$11.2K Hold
122
﹤0.01% 683
2023
Q1
$8.77K Hold
122
﹤0.01% 693
2022
Q4
$10.2K Buy
+122
New +$11K ﹤0.01% 669

Other funds holding AMED

Colonial Trust's AMED Position: Q3 2023 in Review

Colonial Trust sold out of Amedisys (AMED) in Q3 2023, closing a stake of 122 shares — an estimated $11.2K sold.

Colonial Trust first reported a position in AMED in Q4 2022 and held it in 3 quarters. The position peaked at $11.2K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Colonial Trust reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Colonial Trust sold 122 Amedisys shares in Q3 2023, an estimated $11.2K.
  • Colonial Trust first reported a position in Amedisys in Q4 2022 and held it in 3 quarters.
  • Colonial Trust's Amedisys position peaked at $11.2K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Colonial Trust's 13F filing for Q3 2023, filed 13 Nov 2023.